Interleukin-10 improves outcome and alters proinflammatory cytokine expression after experimental traumatic brain injury

Experimental Neurology

Volumn 153, Issue 1, 1998, Pages 143-151

  Knoblach, Susan M ^a   Faden, Alan I ^a  

^a GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

IL 1; IL 10; Inflammation; Injury; TNF

Indexed keywords

INTERLEUKIN 10;

ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BLOOD BRAIN BARRIER; BRAIN EDEMA; BRAIN INJURY; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; INFLAMMATION; MALE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; RAT;

EID: 0031713714     PISSN: 00144886     EISSN: None     Source Type: Journal    
DOI: 10.1006/exnr.1998.6877     Document Type: Article

References (55)

1. Arvin, B., L. F. Neville, F. C. Barone, and G. Z. Feuerstein. 1996. The role of inflammation and cytokines in brain injury. Neurosci. Biobehav. Rev. 20: 445-452.
2. Balasingam, V., and V. W. Yong. 1996. Attenuation of astroglial reactivity by interleukin-10. J. Neurosci. 16(9): 2945-2955.
3. Bean, A. G. D., R. A. Freiberg, S. Andrade, S. Menon, and A. Zlotnik. 1993. Interleukin 10 protects mice against staphylococcal enterotoxin B-induced lethal shock. Infect. Immun. 61(11): 4937-4939.
4. Benveniste, E. N., L. P. Tang, and R. M. Law. 1995. Differential regulation of astrocyte TNF-alpha expression by the cytokines TGF-beta, IL-6 and IL-10. Int. J. Dev. Neurosci. 13: 341-349.
5. Bevilacqua, M. P., J. S. Pober, G. R. Majeau, R. S. Cotran, and M. A. Jr. Gimbrone. 1984. Interleukin-1 (IL-1) induces biosynthesis and cell surface expression of procoagulant activity in human vascular endothelial cells. J. Exp. Med. 160: 618-623.
6. Bevilacqua, M. P., J. S. Pober, M. E. Wheeler, R. S. Cotran, and M. A. Jr. Gimbrone. 1985. Interleukin-1 acts on cultured human vascular endothelium to increase the adhesion of polymorphonuclear leukocytes, monocytes and related leukocyte cell lines. J. Clin. Invest. 76: 2003-2011.
7. Bogdan, C., and C. Nathan. 1993. Modulation of macrophage function by transforming growth factor beta, interleukin-4, and interleukin-10. Ann. N.Y. Acad. Sci. 685: 713-739.
8. Bogdan, C., J. Paik, Y. Vodovotz, and C. Nathan. 1992. Contrasting mechanisms for suppression of macrophage cytokine release by transforming growth factor-β and interleukin-10. J. Biol. Chem. 267(32): 23301-23308.
9. Bradford, M. M. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72: 248-254.
10. Brodie, C. 1996. Differential effects of Th1 and Th2 derived cytokines on NGF synthesis by mouse astrocytes. FEBS Lett. 394: 117-120.
11. Cassatella, M. A., L. Meda, S. Gasperini, F. Calzetti, and S. Bonora. 1994. Interleukin 10 (IL-10) upregulates IL-1 receptor antagonist production from lipopolysaccharide-stimulated human polymorphonuclear leukocytes by delaying mRNAdegradation. J. Exp. Med. 179:1695-1699.
12. Chao, C. C., S. Hu, W. S. Sheng, and P. K Peterson. 1995. Tumor necrosis factor-alpha production by human fetal microglial cells: Regulation by other cytokines. Dev. Neurosci. 17: 97-105.
13. Clark, R. S., J. K. Schiding, S. L. Kaczorowski, D. W. Marion, and P. M. Kochanek. 1994. Neutrophil accumulation after traumatic brain injury in rats: Comparison of weight drop and controlled cortical impact models. J. Neurotrauma. 11:499-506.
14. Cortez, S. C., T. K. McIntosh, and L. J. Noble. 1989. Experimental fluid percussion brain injury: vascular disruption and neuronal and glial alterations. Brain Res. 482: 271-282.
15. Crisi, G. M., L. Santambrogio, G. M. Hochwald, S. R. Smith, J. A. Carlino, and G. J. Thorbecke. 1995. Staphylococcal enterotoxin B and tumor necrosis factor-alpha-induced relapses of experimental allergic encephalomyelitis: Protection by transforming growth factor-beta and interleukin-10. Eur. J. Immunol. 25(11): 3035-3040.
16. de Waal Malefyt, R., J. Abrams, B. Bennett, C. G. Figdor, and J. E. de Vries. 1991. Interleukin 10 (IL-10) inhibits cytokine synthesis by human monocytes: An autoregulatory role of IL-10 produced by monocytes. J. Exp. Med. 174: 1209-1220.
17. Faden, A. I., and P. A. Tzendzalian. 1992. Platelet-activating factor antagonists limit glycine changes and behavioral deficits after brain trauma. Am. J. Physiol. 263: R909-R914.
18. Feigenbaum, J. J., F. Bergmann, S. A. Richmond, R. V. Mechoulam, Y. Kloog, and M. Sokolovsky. 1989. Non-psychotropic cannabinoid acts as a functional N-methyl-D-asparate receptor blocker. Proc. Natl. Acad. Sci. USA 86: 9584-9587.
19. Gerard, C., C. Bruyns, A. Marchant, D. Abramowitz, P. Vandenabeele, A. Delvaux, W. Fiers, M. Goldman, and T. Velu. 1993. Interleukin 10 reduces the release of tumor necrosis factor and prevents lethality in experimental endotoxemia. J. Exp. Med. 177: 547-550.
20. Giulian, D. 1994. The consequences of inflammation after injury to the central nervous system. In The Neurobiology of Central Nervous System Trauma (S. K. Salzman and A. I. Faden, Eds.), pp. 155-164. Oxford Univ. Press, New York.
21. Giulian, D., M. Corpuz, S. Chapman, M. Mansouri, and C. Robertson. 1993. Reactive mononuclear phagocytes release neurotoxins after ischemic and traumatic injury to the central nervous system. J. Neurosci. Res. 36: 681-693.
22. Giulian, D., M. Corpuz, B. Richmond, E. Wendt, and E. R. Hall. 1996. Activated microglia are the principal glial source of thromboxane in the central nervous system. Neurochem. Int. 29: 65-76.
23. Hempel, L., D. Korholz, H. Bonig, M. Schneider, A. Klein-Vehne, J. Packeisen, C. Mauz-Korholz, and S. Burdach. 1995. Interleukin-10 directly inhibits the interleukin-6 production in T-cells. Scand. J. Immunol. 41(5): 462-466.
24. Joyce, D. A., D. P. Gibbons, P. Green, J. H. Steer, M. Feldman, and F. M. Brennan. 1994. Two inhibitors of pro-inflammatory cytokine release, interleukin-10 and interleukin-4, have contrasting effects on release of soluble p75 tumor necrosis factor receptor by cultured monocytes. Eur. J. Immunol. 24: 2699-2705.
25. Jungi, T. W., M. Brcic, S. Eperon, and S. Albrecht. 1994. Transforming growth factor-beta and interleukin-10, but not interleukin-4, down-regulate procoagulant activity and tissue factor expression in human monocyte-derived macrophages. Thromb. Res. 76: 463-474.
26. Kimelberg, H. K., and M. D. Norenberg. Astrocytic responses to central nervous system trauma. In The Neurobiology of Central Nervous System Trauma (S. K. Salzman and A. I. Faden, Eds.), pp. 193-208. Oxford Univ. Press, New York.
27. Koedel, U., A. Bernatowicz, K. Frei, A. Fontana, and H.-W. Pfister. 1996. Systemically (but not intrathecally) administered IL-10 attenuates pathophysiologic alterations in experimental pneumoccal meningitis. J. Immunol. 157: 5185-5191.
28. Krakauer, T. 1995. IL-10 inhibits the adhesion of leukocytic cells to IL-1-activated human endothelial cells. Immunol. Lett. 45(1-2): 61-65.
29. Kremlev, S. G., and D. S. Phelps. 1994. Surfactant protein A stimulation of inflammatory cytokine and immunoglobulin production. Am. J. Physiol. 267: L712-L719.
30. Landis, D. M. 1994. The early reactions of non-neuronal cells to brain injury. Annu. Rev. Neurosci. 17: 133-151.
31. Levy, Y., and J.-C. Brouet. 1994. Interleukin-10 prevents spontaneous death of germinal center B cells by induction of the bcl-2 protein. J. Clin. Invest. 93: 424-428.
32. Lodge, P. A., and S. Sriram. 1996. Regulation of microglial activation by TGF-beta, IL-10, and CSF-1. J. Leukoc. Biol. 60(4): 502-508.
33. McClain, C. J., D. Cohen, L. Ott, C. A. Dinarello, and B. Young. 1987. Ventricular fluid interleukin-1 activity in patients with head injury. J. Lab. Clin. Med. 110: 48-54.
34. McIntosh, T. K., R. Vink, L. Noble, I. Yamakami, S. Fernyak, H. Soares and A. L. Faden. 1989. Traumatic brain injury in the rat: Characterization of a lateral fluid-percussion model. Neuroscience 28: 233-244.
35. Megyeri, P., C. S. Abraham, P. Temesvari, J. Kovacs, T. Vas, and C. P. Speer. 1992. Recombinant human tumor necrosis factor a constricts pial arterioles and increases blood-brain barrier permeability in newborn piglets. Neurosci. Lett. 148: 137-140.
36. Muller, R. 1979. Pentoxifylline-a biomedical profile. J. Med. 10: 307-329.
37. Ott, L. 1989. An Introduction to Statistical Methods and Data Analysis, 3rd ed. PWS-Kent, Boston.
38. Paxinos, G., and C. Watson. 1986. The Rat Brain in Stereotaxic Coordinates, 2nd ed. Academic Press, San Diego, CA.
39. Perretti, M., C. Szabo, and C. Thiemermann. 1995. Effect of interleukin-4 and interleukin-10 on leucocyte migration and nitric oxide production in the mouse. Br. J. Pharmacol. 116: 2251-2257.
40. Piani, D., M. Spranger, K. Frei, A. Schaffner, and A. Fontana. 1992. Macrophage-induced cytotoxicity of N-methyl-D-aspartate receptor positive neurons involves excitatory amino acids rather than reactive oxygen intermediates and cytokines. Eur. J. Immunol. 22: 2429-2436.
41. Pizarro, T. T., K. Malinowska, E. J. Kovacs, J. Jr. Clancy, J. A. Robinson, and L. A. Piccinini. 1993. Induction of TNFα and TNFβ gene expression in rat cardiac transplants during allograft rejection. Transplantation 56: 399-404.
42. Rosenberg, G. A., E. Y. Estrada, J. E. Dencoff, and W. G. Stetler-Stevenson. 1995. Tumor necrosis factor-alpha-induced gelatinase B causes delayed opening of the blood-brain barrier: An expanded therapeutic window. Brain Res. 703: 151-155.
43. Ross, S. A., M. I. Halliday, G. C. Campbell, D. P. Byrnes, and B. J. Rowlands. 1994. The presence of tumour necrosis factor in CSF and plasma after severe head injury. Br. J. Neurosurg. 8: 419-425.
44. Seitz, M., P. Loetscher, B. Dewald, H. Towbin, H. Gallati, and M. Baggiolini. 1995. Interleukin-10 differentially regulates cytokine inhibitor and chemokine release from blood mononuclear cells and fibroblasts. Eur. J. Immunol. 25(4): 1129-1132.
45. Shohami, E., R. Bass, D. Wallach, A. Yamin, and R. Gallily. 1996. Inhibition of tumor necrosis factor alpha (TNFalpha) activity in rat brain is associated with cerebroprotection after closed head injury. J. Cereb. Blood Flow Metab. 16: 378-384.
46. Shohami, E., R. Gallily, R. Mechoulam, R. Bass, and T. Ben-Hur. 1997. Cytokine production in the brain following closed head injury: Dexanabinol (HU-211) is a novel TNF-α inhibitor and an effective neuroprotectant. J. Neuroimmunol. 72: 169-177.
47. Shohami, E., M. Novikov, R. Bass, A. Yamin, and R. Gallily. 1994. Closed head injury triggers early production of TNFa and IL-6 by brain tissue. J. Cerebr. Blood Flow Metab. 14: 615-619.
48. Soares, H. D., R. R. Hicks, D. Smith, and T. K. McIntosh. 1995. Inflammatory leukocytic recruitment and diffuse neuronal degeneration are separate pathological processes resulting from traumatic brain injury. J. Neurosci. 15: 8223-8233.
49. Taupin, V., S. Toulmond, A. Serrano, J. Benavides, and F. Zavala. 1993. Increase in IL-6, IL-1 and TNF levels in rat brain following traumatic lesion. Influence of pre- and post-traumatic treatment with Ro5 4864, a peripheral-type (p site) benzodiazepine ligand. J. Neuroimmunol. 42:177-186.
50. Toulmond, S., and N. J. Rothwell. 1995. Interleukin-1 receptor antagonist inhibits neuronal damage caused by fluid percussion injury in the rat. Brain Res. 671: 261-266.
51. Troy, C. M., L. Stefanis, A. Prochiantz, L. A. Greene, and M. L. Shelanski. 1996. The contrasting roles of ICE family proteases and interleukin-1 beta in apoptosis induced by trophic factor withdrawal and by copper/zinc superoxide dismutase down-regulation. Proc. Natl. Acad. Sci. USA 93(11): 5635-5640.
52. Wright, J. L., and R. E. Merchant. 1994. Blood-brain barrier changes following intracerebral injection of human recombinant tumor necrosis factor-alpha in the rat. J. Neurooncol. 20:17-25.
53. Yakovlev, A. G., and A. I. Faden. 1995. Molecular strategies in CNS injury. J. Neurotrauma. 12: 767-777.
54. Yakovlev, A. G., S. M. Knoblach, L. Fan, R. Goodnight, and A. I. Faden. 1997. Activation of CPP32-like caspases contributes to neuronal apoptosis and neurological dysfunction after traumatic brain injury. J. Neurosci. 17(19): 7415-7424.
55. Zhai, Q-H., N. Futrell, and F-J. Chen. 1996. Cerebral injection of antiinflammatory cytokine IL-10 increases the size of cerebral infarcts in the rat. Soc. Neurosci. Abs. 22: 5. [Abstract]